Skip to Content

Aksys Ltd AKSY

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Aksys develops hemodialysis products and services for patients suffering from chronic kidney failure. The company's automated personal hemodialysis system (the Aksys PHD system) is designed to enable patients to perform hemodialysis in a self-care setting, such as a patient's home. Hemodialysis through the PHD system takes approximately 1-2 hours and can be performed daily. Aksys has offices in Lincolnshire, Illinois.

Contact
Two Marriott Drive
Lincolnshire, IL, 60069
T +1 847 229-2020
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Sep 30, 2006
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 87